General Information
BounceWatch is an independent company data service, not affiliated with aTyr Pharma. To contact aTyr Pharma, visit atyrpharma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does aTyr Pharma compare?
A PDF of aTyr Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting aTyr Pharma soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is aTyr Pharma on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About aTyr Pharma
Business keywords: Biotherapeutics, Drug discovery, Biologics, Immunomodulation, Rare diseases, Orphan diseases, Autoimmune diseases, Protein biologics, Inflammatory lung diseases, Extracellular pathways, tRNA synthetases, Neuropilin-2 receptor, Preclinical development, Intellectual property, Life sciences
Funding Rounds & Investors (11)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $50.00M | - |
|
08 Feb 2023 |
| Post IPO Equity | $86.30M | - |
|
15 Sep 2021 |
| Post IPO Equity | $20.70M | - |
|
10 Mar 2020 |
| Post IPO Equity | $45.00M | 3 | 28 Aug 2017 | |
| Post IPO Debt | $20.00M | 2 |
Solar capital, Silicon Valley Bank
|
21 Nov 2016 |
| Series E | $76.00M | 10 | 31 Mar 2015 | |
| Series D | $49.00M | 5 | 29 Jul 2013 | |
| Debt Financing | $10.00M | 1 |
Silicon Valley Bank
|
29 Jul 2013 |
| Series C | $23.00M | 4 | 26 Oct 2010 | |
| Series C | $12.00M | 3 | 15 Sep 2009 |
aTyr Pharma Alternatives & Competitors
View All AlternativesDeveloping novel medicines for patients with difficult-to-treat cancers and other serious diseases.
Developing a new class of biologics for patients with respiratory and inflammatory diseases.
Changing the course of CNS disease
FAQ About aTyr Pharma
Source: BounceWatch company record for aTyr Pharma, https://bouncewatch.com/company/atyr-pharma, updated 30 December 2024. When citing, please name BounceWatch and link this page.